No Data
No Data
No Data
No Data
No Data
Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders Until January 12, 2024
Aridis Pharmaceuticals, Inc. (OTC QB: ARDS) today announced that its 2023 Annual Meeting of Stockholders ("Annual Meeting"), scheduled for Friday, December 15, 2023, was convened and adjourned, without any business being conducted, due to lack of the requisite quorum.
GlobeNewswireDec 15, 2023 16:15 ET
HC Wainwright & Co. Reiterates Buy on Aridis Pharmaceuticals, Maintains $2 Price Target
HC Wainwright & Co. analyst Vernon Bernardino reiterates Aridis Pharmaceuticals (OTC:ARDS) with a Buy and maintains $2 price target.
BenzingaNov 6, 2023 07:05 ET
Promising Developments and Value Proposition: A Buy Rating Analysis of Aridis Pharmaceuticals
TipRanksNov 6, 2023 06:33 ET
Aridis Pharmaceuticals Q3 EPS $0.00 Up From $(0.47) YoY, Sales $417.00K Up From $399.00K YoY
Aridis Pharmaceuticals Q3 EPS $0.00 Up From $(0.47) YoY, Sales $417.00K Up From $399.00K YoY
BenzingaNov 3, 2023 16:16 ET
Aridis Pharmaceuticals Price Target Cut to $2.00/Share From $10.00 by HC Wainwright & Co.
Aridis Pharmaceuticals Price Target Cut to $2.00/Share From $10.00 by HC Wainwright & Co.
Dow JonesOct 20, 2023 14:04 ET
Aridis Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Aridis Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow JonesOct 20, 2023 14:04 ET
chris from queensOP : why does Sabby Management own just over 5% of the company shares how is that even possible? Didn't the SEC just nail them and Hal D. Mintz their partner for manipulating the stock market and commiting fraud. I believe they can no longer do business that's the least of their worries..can MooMoo answer this or can anybody in the community? Just as to can and how Sabby Management can own just over 5% of the float of this stock.. thanks in advance
No Data
No Data